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ABSTRACT
A high degree of homology exists within the catalytic subunits of many
ser/thr phosphatases, noteably PP1, PP2A, and PP2B. These enzymes are
regulated by regulatory proteins in trans, or by inhibitory elements within the
catalytic subunit itself. In order to better understand both the mechanism of
catalysis which these phosphatases most likely share, as well as the intricacy of
the multi-domained structure of calcineurin, a study was initiated on lambda
phosphatase and calcineurin(PP2B) truncation mutants. Calcineurin clones
containing only the N-terminal sequence which corresponded to the entire
lambda phosphatase sequence (as viewed from sequence alignments) were
completely inactive in the pNPP and phosphoRII peptide phosphatase
assays,although less severe truncations did display catalytic activity. In
keeping with reported results, the Calcineurin B regulatory protein greatly
stimulated the activity of one of the truncation mutants which retained a
Calcineurin B binding domain.
Thesis Supervisor: Dr. Jun Liu
Title: Assistant Professor of Chemistry and Biology
CHAPTER 1
Kinetic Studies of X Phosphatase
Protein kinases have long been regarded as essential for regulation of a wide range of
biochemical processes; it is only relatively recently that protein phosphatases have gained
recognition as important regulatory molecules as well. Protein phosphatases can oppose the
transient effects of protein kinase stimulation or stimulate processes themselves which can be
likewise antagonized and regulated by kinase action. Phosphatases have been implicated in
such diverse functions as transcriptional control, cell cycle, cell differentiation, glycogen
metabolism, growth factor responses, development, and many other cellular processes.
There are two main classes of phosphatases, categorized based on substrate specificity:
protein tyrosine phosphatases (PTPases) and serine/threonine phosphatases. ( The presence of
in vivo phosphohistidine has been documented, having gone unnoticed until relatively recently
due to the lability of the phosphohistidine bond to standard amino acid sequencing/analysis
conditions; some of the tyr/ and ser/thr phosphatases, including PP1, PP2A, and PP2C, have
shown some phosphohistidine phosphatase activity in in vitro assays.--Kim et al., 1993)
These two classes of enzymes appear to have quite different catalytic mechanisms, as well as
different substrate specificities.
Protein tyrosine phosphatases have been studied extensively in the past several years.
With the partial amino acid sequence determined for PTP1B in 1988 (Tonks et al., 1988), a new
family of protein phosphatases was defined. Some protein tyrosine phosphatases contain
sequences homologous to known domains which target the phosphatase to specific subcellular
compartments, thereby effectively limiting the amount of possible substrates by lack of
availability. They may also contain protein binding domains, such as SH2 and SH3 domains.
These binding domains, located outside of the active site of the enzyme, may afford a more
stable interaction with particular substrates able to bind these sequences. Some PTPases, such
as hLAR, carry cytoskeletal domains which imply a role for PTPases in cell architecture and
morphology. Other PTPases include dLAR, which is expressed in the central nervous system
in drosophila, and, with its extracellular domain similar to N-CAM (neural cell adhesion
molecule), may be involved in axonal development; VH1 from vaccinia virus, with as yet
undetermined function; dPTP61F in drosophila with its two isoforms, generated by alternate
splicing-- one with a hydrophobic C-terminus which localizes to the particulate fraction, and
one with a basic C-terminus which is targetted to the nucleus, potentially involved in
transcriptional regulation; Cdc25, which activates MPF by dephosphorylation thereby
triggering entry into the cell cycle; and many others (Walter and Dixon, 1993).
Mechanistic studies on CD45 and LAR include analysis of Cys->Ser point mutations in the
wildtype enzyme and labeling studies with the sulfhydryl modifier iodoacetimide (14C-
labeled iodoacetimide labels the enzyme stoichiometrically, with concommitant inactivation
of phosphatase activity) These experiments, along with the detection of a "trapped"
phosphoenzyme intermediate, demonstrate that the mechanism of catalysis proceeds via a
phosphocysteinyl enzyme intermediate (reviewed in Walton and Dixon, 1993). Catalytically
inactive PTPases with this characteristic cysteine mutated to serine have been used as reagents
to probe for substrates, as in the case of PTPIB where the catalytically inactive Cys-->Ser
mutant was shown to bind the epidermal growth factor receptor, a receptor tyrosine kinase, in
vivo by immunoprecipitation of the EGFR/PTPIBCS complex (Milarski et al., 1993). The
crystal structure of the bovine liver low molecular weight protein tyrosine phosphatase has
been determined. This study defines aputative phosphate binding pocket, occupied by a sulfate
anion (the protein was crystalized from an ammonium sulfate solution) which purportedly
corresponds to the phosphate of a phosphoprotein substrate. The pocket is composed of a
stretch of seven continous residues, including several basic residues, such as Arg18, which would
make contacts to the phosphate. This pocket is also lined with two cysteine residues, one of
which has been proposed to initiate a nucleophilic attack on the phosphate, generating a
Cysl2 phosphoprotein intermediate. Both the low molecular weight PTPase and PTP1B share
a CXXXXXR motif.
Protein serine/threonine phosphatases constitute the other major family of protein
phosphatases. Ser/thr phosphatases were originally classified according to their substrate
specificity (mainly activity toward phosphorylase kinase), metal requirements, and
susceptibility toward inhibitor proteins. PP1, PP2A, and PP2B share homology in the amino
acid sequences of their catalytic subunits, whereas PP2C seems to be the product of an
evolutionarily unrelated gene. PP1 has increased specificity for the 0 subunit of
phosphorylase kinase over the a subunit and its activity is blocked by inhibitor-1 and
inhibitor-2, whereas PP2A, PP2B, and PP2C preferentially dephosphorylate phosphorylase ox
and their activity is not blocked by inhibitors 1 or 2. The phosphatase activity of PP2C is
Mg2+-dependent, while the activity of PP2B (= calcineurin) is Ca2+-dependent and is further
activated by Mg 2+ and Mn2+ (reviewed in Cohen, P. et al., 1988).
While it seems likely that the catalytic mechanism for dephosphorylation would be
conserved for PP1, PP2A, and PP2B with the striking conservation of tens of residues found in
the N-terminal half of these enzymes (see Figure 1), substrate specificity varies widely. Much
of this ability for similar catalytic subunits to discriminate between substrates is probably
conferred by the association of several different types of regulatory subunits with the catalytic
subunits. Both the catalytic and regulatory subunits of each of the four previously mentioned
phosphatases (PPases) have several isoforms as well. Taking into account the large number of
different possible holoenzymes that can be generated along with the effects of subcellular
localization, one can imagine an exquisitely fine-tuned substrate specificity, far beyond what
was originally recognized, for ser/thr protein phosphatases.
PP1 has been shown to associate with a wide variety of regulatory subunits in mammalian
cells, often in a tissue-specific manner. For example, the G subunit (glycogen- binding subunit)
which is expressed only in skeletal muscle, mediates the association of PP1 with glycogen,
thereby bringing PP1 into close proximity of its phosphoenzyme substrates involved in glycogen
metabolism (reviewed in Shenolikar, 1994). In muscle tissue, PP1 associates with the M
complex (composed of two proteins, 130kD and 25kD) and binds to smooth muscle myosin (Dent
et al., 1992). Dephosphorylation of myosin results in muscle relaxation (Gong et al., 1992) .
Hagiwara et al. (1992) have implicated PP1 in hormone signalling pathways: they find
that the attenuation of the cAMP response pathway is dependent on functional PP1. The cAMP
response pathway operates by activating CREB, a transcriptional activator/binding protein
which binds to CRE's (cAMP Response Elements). Dephosphorylation of the activated CREB at
Ser13 correlates with a decrease in CRE- specific transcription. Cotransfection of neuronal PC-
12 cells with PP1 causes decreases in levels of CRE-reporter gene transcription from a CRE-CAT
reporter plasmid, consistent with the deactivation of active CREB by PP1-catalyzed
dephosphorylation. PP2A cotransfection, on the other hand, actually increased CAT activity
in vivo . In in vitro assays, the presence of inhibitor-2 (a protein inhibitor specific for PP1)
causes an increase in CREB phosphorylation in nuclear extracts. Microinjection of inhibitor-1
into the cytoplasm of CRE-CAT transfected REF-52 cells or cotransfection of a plasmid encoding
inhibitor-1 likewise caused an increase in CAT activity as compared to control cells
microinjected with IgG1. These results support an in vivo role for PP1 in attenuation of hormone
stimuli which activate cAMP-dependent pathways.
PP1 has also been shown recently to bind to human Rb (retinoblastoma tumor suppressor
gene) , by means of the yeast two-hybrid system, immunoprecipitation, and biochemical assays
involving phosphatase inhibitors. This association is abbrogated in late G1 as cells progress
through the cell cycle and Rb becomes hyperphosphorylated and unable to bind to DNA. PP1
activity has been shown, by okadaic acid inhibition studies, to reside mainly in the nucleus
during G2-M (5:1 Nuclear PPI: Cytoplasmic PP1) , and during all other stages of the cell cycle
PP1 activity in nuclear extracts is about twice the amount of activity associated with the
cytoplasmic and particulate fractions (Dohadwala et.al, 1994). In similar experiments,
microinjection of PP1 into either the nucleus or the cytoplasm of REF-52 (Rat Embryo Fibroblast)
cells 10-12 hours after serum stimulation of GO cells corresponded to an increased nuclear
localization of Rb and reduced levels of BrdU incorpororation, as detected by
immunofluorescence staining of normal and in-situ nucleus-extracted cells. Such findings suggest
a link between G1 arrest and the phosphosphorylation state of Rb, as influenced by PP1
activity. Involvement of PP2A is possible as well, as microinjection of PP2A C subunit (but not
AC) had similar effects on Rb localization and BrdU incorporation (implying perhaps that a
different endogenous A subunit is confering this substrate specificity/activity on the C subunit of
PP2A).(Alberts et al.,1993b).
In addition to the regulatory influences of additional subunits on PP1, the catalytic subunit
itself has been proposed to be regulated by covalent modification--specifically, by
phosphorylation. A C-terminal sequence of the catalytic subunit of PP1, T-P-P-R , previously
identified as a motif which can be phosphorylated by a cyclin-dependent kinase (Cdc2/Cyclin
A), has been shown to be phosphorylated by cdk in vitro. This phosphorylation inactivates
PP1 activity toward phosphorylase a substrate. These experiments further support a role for
PP1 in regulation of the cell cycle.
PP2A is involved in a wide variety of cellular processes as well. The holoenzyme is
composed of three subunits- a catalytic subunit as well as A and B regulatory subunits. Again,
there are several different genes encoding these subunits in a given organism, as well as
different spliceoforms of each gene, giving rise to a huge number of possible PP2A activities
with differing substrate specificities.
In S. cerevisiae, a connection has been found between PP2A and RNA Polymerase III. tpd3
strains (with mutations in the yeast PP2A A subunit homologue, Tpd3) exhibit defective
transcription of tRNA genes. Extracts of tpd3 cells grown at 230C and assayed for tRNA
synthesis in in vitro transcription reactions using a tRNA3Glu DNA template were not
competent for tRNA transcription as compared to TPD3 extracts. Tpd3 mutant extracts grown at
370C had undetectable levels of tRNA transcription. Reconstitution experiments in which
purified RNA polymerase III or TFIIIB (part of the initiation machinery of pol III), but not
TFIIIC, were added to tpd3 extracts supported tRNA synthesis to levels similar to that of TPD3
extracts treated similarly. These results indicate that the A subunit of PP2A plays some role in
pol III regulation. Interestingly, the loss in function is not reversible by addition of okadaic
acid to the transcription reactions. This finding suggests that increased phosphatase activity
of the uncomplexed C subunit cannot be the cause of the transcription defect. Rather, Van Zyle
et al. (1992) suggest, changes in substrate specificitymay induce PP2A phosphatase activity
toward a protein which then becomes inhibitory to the transcription apparatus by interaction
with one or more of its components. Changes in the phosphorylation state of one of the subunits
of RNA pol III itself could be affected by the alteration of PP2A substrate specifity as well
(Van Zyle et al., 1992; Shenolikar, 1994). Arndt et al. (1989) have similarly discovered a gene
which seems to be involved in RNA pol II transcription called SIT4, which encodes a 36 kD
protein with 50% homology to the bovine PP2A catalytic subunit. sit4 mutants exhibited
increased levels of HIS4 gene transcription (normally transactivated by three other genes
which have been knocked out in the S. Cerevisiae strain used in this study). It is unknown
whether RNA pol II is directly activated by dephosphorylation mediated by the SIT4 gene
product, or if the linkage is less direct, perhaps involving the dephosphorylation and
activation of another transcription factor.
PP2A has also been implicated in drosophila development. Drosophila possesses, in
addition to a catalytic subunit with 94% homology to the human PP2A catalytic subunit, an A
subunit (Pr65) and a B subunit (Pr55-78% homologous to the human PR55a, human PR55P(, and
S. Cerevisiae Cdc55). B subunit mRNA is present in drosophila imaginal discs at increased
levels, and drosophila with a mutatedPr55 gene (i.e. the twins mutation) develop altered
wings. The aar mutant (abnormal anaphase resolution )possesses a mutation which is linked to
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twins, and whose phenotype can be rescued by either the wild type gene for twins, or the wild
type PR55 gene. aar 1 mutants display a range of phenotypes, including overcondensed
chromosomes, hyperploidy, and lagging chromosomes which are defective in pole migration
(Gomes et al., 1993). The aarl mutation is lethal at the late larval-early pupal stage and can
be rescued with the wild type PR55 gene (Mayer-Jaekel et al., 1993). In other organisms,
though, like S. Cerevisiae, it seems that there is a functional redundancy regarding PR55, as
Cdc55 null mutants grow nearly normally and Cdc55 mutants have a different set of phenotypes
from the Drosophila aar mutants (Healy et al., 1991).
Another area in which PP2A functions is signal transduction. The A subunit has been
demonstrated to be a key regulator of specificity in several studies involving the effect of PP2A
activity on c-jun transcriptional activation. In vivo experiments show that F9 cells transfected
with a CAT reporter gene downstream of an AP-1 site as well as c-jun under an RSV promotor
show three times as much CAT activity when cotransfected with the PP2A C subunit than
control levels or levels obtained when the cells are cotransfected with AC complexes of PP2A.
Cells not transformed with c-jun show an increase in CAT activity when cotransfected with
PP2Ac as well, supporting a role for endogenous c-jun ,as well as overexpressed c-jun, in
mediating the observable increase in AP-1 transactivation. Similar results are obtained from
microinjection studies by the same authors (Alberts et al., 1993a).
Studies on the interaction of PP2A with DNA tumor viruses have suggested roles for PP2A
in viral transformation and signal transduction pathways of transformed cells as well. The
binding of PP2A to specific viral tumor antigens causes either a change of substrate specificity,
or inhibition of phosphatase activity which is compatible with the viral program. For
example, the polyoma virus middle T antigen binds the AC complex of PP2A and thereby
increases its activity as a protein tyrosine phosphatase over the native holoenzyme. The
SV40 small t antigen binds either the AC complex or the A subunit alone, and this binding can
be competitively reversed by addition of certain types of B subunit, implying that it acts as a
surrogate B subunit which binds the A subunit in a similar manner to that of the B subunit. The
ternary complex (i.e. the AC complex incubated with small t) shows reduction or enhancement
of activity toward certain substrates, demonstrating increased activity toward histone H1 at
50-100 nM small T as well as decreased activity toward myelin basic protein and myosin light
chains in vitro (Yang et al., 1991). One of the substrates which the ternary complex exhibits
reduced activity towards in vitro is the SV40 large T antigen, which, when phosphorylated,
binds to the SV40 origin of replication and directs viral replication and transcription (Prives,
1990; Farmer et al., 1992). SV40 small t effectively blocks PP2A-mediated dephosphorylation
of SV40 large T antigen. In the presence of small t, the AC complex of PP2A exhibits a 3-fold
reduction in in vitro phosphatase activity on large T immunoprecipitates containing large
T/p53 complexes, as measured by 32P release. Two dimensional peptide maps of large T
incubated with PP2A or p53 incubated with PP2A, both in the absence and presence of small t,
show specific changes in the phosphopeptide map which indicate blockage of PP2A-catalyzed
dephosphorylation of specific sequences-for AC, ABC, and C forms of PP2A (Scheidtmann et
al., 1991), indicating an interaction between PP2A and both p53 and SV40 large T.
PP2A-mediated dephosphorylation of MEK1 and ERK1 is also inhibited by small t in vitro
when mono-Q FPLC-purified PP2A AC complexes or C subunit are incubated withpurified SV40
small t antigen and ERK1 or MEK and kinase activity measured by 32p incorporation in a
myelin basic protein substrate (Sontag et al., 1993). When monkey kidney CV-1 cells are
transfected with small t, increased phosphorylation of MEK and ERK-2 can be detected which
correlates with a higher level of basal ERK and MEK activity, implying an inhibition of PP2A
activity. Immunoprecipitates of ERK2 in transformed cells which were immunoblotted with
anti-small t antibodies were found to contain bound small t antigen, as did a GST fusion protein
of the A subunit. The activity of Raf-1 (a proposed substrate of PP1) is unaffected, as assessed
by a coupled kinase assay in which the ability of small t to modify the activity of
immunoprecipitated Raf-1 from CV-1 cells transformed with small t is tested by incubation
with MEK1 and a kinase-defficient ERK2. Immunoprecipitated Raf-1 from transformed and
nontransformed cells exhibited similar abilities to activate MEKl-catalyzed phosphorylation
of ERK2, both in the absence and presence of EGF (Sontag et al., 1993). These results
complement the findings of Kovacina et al. (1990) that the insulin-induced activation of Raf-1
kinase activity, which correlates with its phosphorylation on serine, is reversed by PP1. Raf-
1 immunoprecipitates of cellular extracts of HeLa cells treated with exogenous PP1 exhibit
Raf-1 kinase activity at control levels.
PP2B, otherwise known as calcineurin, is a ser/thr phosphatase which mediates the effects
of transient increases in cytosolic Ca2+. In addition to the catalytic subunit (which shares
homology with PP1 and PP2A), PP2B is regulated by a calcium-binding B subunit as well as by
calmodulin. Both the A (catalytic subunit) and B subunits have several different genes which
give rise to different isoforms of calcineurin. These proteins are expressed differentially in
several tissues, including brain, hemopoitic cells, and testes. Similar genes encoding both
subunits have been found in lower organisms as well, such as Neurospora Crassa (Higuchi et
al., 1991) and S. Cerevisiae (Cyert et al., 1991). Calcineurin has been found to be critical in
several different cellular processes, in which it acts as a calcium sensor in the cell; upon
increases in intracellular free calcium concentrations, calmodulin binds to calcineurin, resulting
in an activation of the phosphatase activity associated with calcineurin (to be discussed in
depth in Chapter 2 ). Immunosuppressants cyclosporin A and FK506 were discovered to bind a
cyclophilin protein present in cellular extracts. This drug/immunophilin complex was found to
bind to calcineurin, hence identifying calcineurin as a protein important for T cell activation in
response to antigenic stimuli (Liu et al., 1991-referenced in Chapter 2). Clipstone and Crabtree
(1992) demonstrated that overexpression of calcineurin in Jurkat cells transformed with a vector
containing a gene encoding calcineurin as well as a vector containing the protein alkaline
phosphatase downstream of multiple copies of NF-AT (Nuclear Factor of Activated T cells; a
transcription factor which enhances transcription of Interleukin-2. They were able to show
that NF-AT-dependent expression was sensitive to concentrations of CsA or FK506 that were
inhibitory to calcineurin. NF-AT itself is a dimer, composed of one subunit which is
synthesized after stimulation of PKC activity in the T cell, and another subunit which exists in
the cytoplasm before stimulation and translocates to the nucleus, where it forms a heterodimer
with the other subunit and activates genes such as IL-2 involved in T cell activation.
Calcineurin may be directly involved in this translocation of NF-ATp, which involves
dephosphorylation of the cytosolic NF-ATp (McCaffrey et al., 1993 and references therein).
PP2C shares no sequence homology with the other ser/thr phosphatases discussed above. It
is classified as a class "2" (PP"2"A) enzyme because it preferentially dephosphorylates the A
subunit of phosphorylase kinase over the B subunit. Unlike PP2A and PP1, PP2C is insensitive
to the inhibitor okadaic acid, even at 1tM concentrations (reviewed in Cohen et al., 1990). The
in vivo activity of PP2C has not yet been studied, although it seems to be expressed in most
types of mammalian tissue, most notably in liver, heart, brain, and muscle. It displays in vitro
activity against glycogen synthase and myosin light chains, both with a Km of less than 10 RM.
It has a high level of activity toward HMG-CoA reductase and reductase kinase, both enzymes
involved in cholesterol metabolism, in vitro (Ballou and Fischer, 1986; Shenolikar, 1994). It is
possible that PP2C is the major regulator of cholesterol synthesis in vivo , although
experimentation which adresses this question has not yet been performed.
Recently several phosphatases have been discovered which possess dual specificity and
thus do not fit neatly into the two proposed categories above; these proteins act both as ser/thr
phoshphatases and as phosphotyrosine phosphatases. Two examples of such proteins are
Cdc25 and 3CH134 (MKP-1). Both of these proteins share the most homology with vaccinia
viral protein VH1 (25% amino acid identity between Cdc25 and VH1 in the PTPase domain,
and 26% identity between 3CH134 and VH1 in the PTPase domain) (Walter and Dixon, 1993).
Cdc25 plays an important role in the cell cycle: it dephosphorylates MPF, thereby activating it
and inducing mitosis. MPF (Mitosis Promoting Factor), is a heterodimer of two subunits,
namely, a Cdc2 ser/thr kinase subunit complexed with a regulatory Cyclin B subunit. The
kinase has been shown to be regulated by phosphorylation at Tyr15, Thr14, and Thr167. The
Tyrl5 and Thr14 sites represent negative regulatory sites. These residues are phosphorylated
in the inactive Cdc2/cyclin B complex, and both can be dephosphorylated by Cdc25 as can be
detected by gel mobility shifts as well as MPF activity induced by Cdc25 as opposed to other
PTPases. A Cdc25 mutant with a cys-->ser mutation in the conserved PTPase active site motif
CXXXXXR has been found to be inactive regarding bothThrl4 and Tyr15 dephosphorylation,
implying that Cdc25 employs the same mechanism to dephosphorylate tyrosine as it does to
thr/ser (ser activity was found against ser-phosphorylated casein by another group of
investigators).
3CH134 has been similarly characterized as a dual specificity enzyme. It has been
suggested that 3CH134 acts as a feedback inhibitor to the MAP kinase pathway in that it is
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induced upon serum stimulation and acts to downregulate MAP kinase activity by
dephosphorylating MAP kinase on tyrosine and threonine residues, both in vivo and in vitro . In
vitro dephosphorylation catalyzed by 9E10 immunoprecipitates from Cos cells transfected
with Myc epitope-tagged 3CH134 was detected at Tyr andThr (by two dimensional
phosphamino acid analysis) against recombinant phosphorylated and purified MAP kinase.
The Cys-->Ser mutant (3CH134CS) showed lack of dephosphorylation of both tyrosine and
threonine. In vivo dephosphorylation of tyrosine was detected, by immunoblot analysis with
antiphosphotyrosine antibodies, in PTPase inhibitor-treated lysates of transformed Cos cells
stimulated for five minutes with serum after a period of serum starvation. Again, the CS
mutant showed MAP kinase tyrosine phosphorylation levels to be similar to that of control
levels of untransformed cells. As with other catalytically inactive PTPases, the 3CH134CS
mutant was shown to be capable of binding endogenous MAP kinase in myc-tagged 3CH134CS-
transformed Cos cells, as evidenced by the ability to immunoprecipitate MAP kinase from
cellular extracts using the 9E10 anti-myc epitope antibody. Evidence for the involvement of
3CH134 in feedback control of the MAP kinase in vivo was derived from an experiment
correlating the timecourse of 3CH134 expression with the kinetics of dephosphorylation and
inactivation of MAP kinase. Starting at one hour after serum stimulation of NIH3T3 serum-
starved cells, 3CH134 protein becomes immunoprecipitable with 9E10 antibodies. Concurrently,
the appearance of faster-migrating species signifying less phosphorylated forms of MAP
kinase was noted on SDS-PAGE gels, as well as a corresponding decrease in the kinase activity
of these new MAP kinase forms, as detected in an in-gel kinase assay using myelin basic protein
as a substrate. This downregulation of MAP kinase activity was completely abbrogated by the
inclusion of cycloheximide in the serum used to induce activation of the MAP kinase pathway,
further supporting the observation that the kinetics of expression of new 3CH134 protein and
the decrease in MAP kinase activity are linked (Sun et al., 1993).
Given the importance of protein phosphatases in so many aspects of cell function- from cell
cycle regulation to hormonal stimulation, from transcription to cell differentiation and
development-- we decided to initiate a study on one particular phosphatase in the hopes of
generalizing mechanistic characteristics to other enzymes with catalytic subunit homology
such as PP2B. In 1988, Cohen et al. reported the presence of a putative protein phosphatase in
bacteriophage X which showed 35% identity to rabbit PPla and PP2Aa in the N terminal half
of the open reading frame, designated ORF221 (Figure 1)(Cohen et al., 1988). The following
year, a study was published by the same group which demonstrated that the X gtl0O strain of
bacteriophage X did indeed encode a phosphatase with in vitro activity toward 32p-labeled
casein and phosphorylase. Lysates from bacteria infected with a different strain called X gt11,
which contains an N-terminal deletion of ORF221 including the first of three sequences
conserved in other ser/thr phosphatases such as PP1, PP2A, and PP2B, did not exhibit any such
phosphatase activity. These results point to a new phosphatase, of low molecular weight (25
kD), which would be a prime candidate for mutational studies in order to identify which
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Figure 1. Sequence alignment of Calcineurin, X phosphatase, PP1, and PP2A.
Identical residues across the four enzymes are marked.
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residues play a role in catalysis. Knowledge of the active site of ORF221 could be applied to
other ser/thr PPases. Identification of residues important for substrate binding could yield Km
mutants which bind more tightly to the substrate, or inhibit the release of the
dephosphorylated product after turnover-- such a mutant could possibly be used in a fashion
similar to the cys->ser mutant of PTPases, i.e. function as a substrate binding protein and
therefore as a reagent to identify in vivo substrates of these PPases.
With these aims in mind, we proceeded to clone and purify ORF221, and define kinetic
parameters for the wild type enzyme.
Materials and methods
Cloning of ORF 221/ lambda phosphatase. The lambda DNA used as a template for PCR
cloning was strain WcI indlts857Sam7, whose genome was initially sequenced by Sanger et al.
(1982). Bases 43228-43890 on the right arm of this lambda phage encodes the full length
ORF221. Primers were designed to include a 5' EcoRI restriction site and a 3' HindIII restriction
site in order to facilitate cloning into a pHNI+ plasmid carrying a tac promoter uptstream of
the MCS. The sequence of the 5' primer was: 5'-AGCCTAGAATT
CCTGAAGGAGAGAACACGATGCGCTATIACGAAAAAAT-3' (LPIT17 primer); the sequence
of the 3' primer was: 5'-GCATGCAAGCT TCATGCGCCTTCTCCCTG-3' (LP2T18 primer, from
Bio-Synthesis). [Italics denote bases added to the clone throughPCR. Restriction sites are
underlined.] PCR conditions included 4 mM MgCl2, 1 •M each primer, and 10 ng of template
DNA (PCR reagents were from Perkin-Elmer). PCR method was as follows: 960C, 6 '; 960C, 1' /
450C, 1'/ 720C,1.5'--3 cycles; 940C,1'/ 450C,1'/720C,1.5'--30 cycles; 720C, 6'/ 250C, 30'/ 40C,999'.
PCR DNA was restriction- digested with the appropriate enzymes and further purified with
Gene Clean (Bio-101, Inc.). Miniprep plasmid DNA was similarly digested, and heated to
650C to inactivate restriction enzymes. Ligations were performed at 160C overnight with T4
DNA ligase (Promega). The ligation mixture was transformed into competent DH5a bacteria.
Clones were selected on LB plates containing ampicillin. After restriction digestion of the
plasmid DNA to verify the presence of proper length inserts, the clones were sequenced by
dideoxy sequencing methods using Sequenase (USB).
Expression and purification of recombinant A phage. The pHN1+/ORF221 plasmid was
transformed into XA90 bacteria. Overnight cultures innoculated into 10 mis of LB containing 100
gg/ml ampicillin were innoculated into 1 liter of LB containing 100 ig/ml ampicillin and
induced to a final concentration of 2mM IPTG (isopropyl-o-D-thio glucopyranoside; Sigma)
when the culture reached an OD596 of 0.6. The bacterial cultures were harvested after a 2.5-
hour induction by centrifugation at 5,000 x g for 10 minutes. The pellet was washed once in lysis
buffer (50 mM Tris, 1 mM EDTA, 1 mM EGTA, 50 mM NaCl, pH7.5) and resuspended at 4 ml
lysis buffer/g pellet. Cells were lysed by two passes at 12,000 psi in a French Press. The cell
debris was removed by centrifugation at 10,000 x g for 20 minutes. DNA was precipitated and
removed from the extract by adding 1/5 volume of 2% (w/v) protamine sulfate (Sigma) to the
extract at 4oC, stirring, for 20 minutes. After centrifugation , the extract was NH4SO4-
precipitated by adding ammonium sulfate to 60% at 40C, stirring, for 20 minutes and then
centrifuged again at 10,000 x g for 20 minutes. The pellet was resuspended in lysis buffer and
loaded directly onto a 100 x 3 cm G-75 gel filtration (Pharmacia) column preequilibrated in
lysis buffer (all at 4oC). The column was developed by gravity and fractions collected were
assayed for protein content by A 280 and SDS-PAGE electrophoresis, as well as for activity in a
pNPP phophatase assay. Active fractions were pooled and concentrated with an Amicon
diafiltration system and dialyzed into lysis buffer + 1mM DTT+30% glycerol. Protein
concentrations were measure by Bradford assay using BSA (Bovine Serum Albumin; Boehringer-
Mannheim) as a protein standard. Protein was then stored at -200C.
Phosphatase assays . Assays were run at ambient temperature in 1x assay buffer: 50 mM
Tris, 1mM EDTA and 1mM EGTA, pH 7.5, including 1 mg/ml BSA. Enzyme dilution buffer was
identical to the assay buffer. When present in the assay buffer, the final concentration of Mn 2+
was 2 mM MnCl2; when present in the assay buffer, the final concentration of Mg2+ was 10 mM
MgCl2. The reaction was started by adding pNPP (para-nitrophenylphosphate; Gibco-BRL)
to the assay mixture immediately after addition of enzyme to the assay buffer; the reaction
was mixed, and the rate of change in OD410 was monitored by spectrophotometer (Hewlett-
Packard), corresponding to the rate of appearance of the para-nitrophenol anion. Kinetic
parameters and their standard deviations were calculated on Kaleidagraph, using the
extinction coefficient of 1.8 x 104 M-1 cm-1 for paranitrophenolate.
Results and Discussion
From a one liter culture of bacteria, 24.6 mgs of ORF221 were obtained after ammonium
sulfate precipitation and G-75 purification, corresponding to about 50% of the ammonium
sulfate pellet and 49% of the initial crude after DNA precipitation (see Figure 1). At this
stage of purification, the G-75 eluate corresponded to approximately a two-fold purification
over the crude extract (see Figure 1 and Table I). Crude extracts of untransformed XA90 showed
levels of activity slightly above background, whether in the presence of Mn2+ or Mg 2+; crude
extracts containing ORF221 were stimulated 7- to 8-fold by inclusion of 2 mM Mn 2+ in the assay
buffer over the level of activity obtained with 10 mM Mg2+, which was barely above
background levels. Assays on protein from a 30-45% ammonium sulfate pellet showed a greater
than 10-fold stimulation of Mn 2+ over Mg2+ activity (data not shown) in 20 mM pNPP (a
phosphotyrosine analogue). A higher level of activation was obtained if Mn 2+ was included
in the enzyme dilution buffer and the preincubation time lengthened, suggestive of a slow
14
123
97--
66 -
45 -
31--
22--
Figure 2. Purification of ORF221. Different stages of the purification of X phosphatase and
their protein profiles (12% Acrylimide SDS-PAGE gel). Lane 1, 10 gig crude cellular extracts of
XA90 transformed with the pHN1+/ORF221 plasmid. Lane 2, 10 gig 60% ammonium sulfate
pellet resuspended in lysis buffer. Lane 3, 5 jtg of G-75 gel filtration-purified protein at the
expected molecular weight of 25 kD.
transition of the enzyme to a more active conformation, as has been suggested previously for
phosphatases such as PP2B (Ballou and Fischer, 1986). The purification process involved
precipitated by either addition of protamine sulfate to the extracts, or by DNAse treatment;
both G-75 enzyme preparations gave similar activities at 20 mM substrate, and addition of
protamine sulfate of up to 60 pg/ml reaction was found to be neither inhibitory nor stimulatory
to the rate of reaction. In this, ORF 221 differs from rabbit PP2AO,i, and 2 isoforms which are
stimulated by 5 gg/ml protamine (Cohen,P. et al., 1988).
The protein profile of the G-75 -purified protein indicates the presence of a contaminating
lower band. This band was present whether or not protease inhibitors were included in the
lysis buffer. The lower band was not separable from the 25 kD band ( migrating near the
expected molecular weight for ORF221 of 25, 222 daltons) visible upon IPTG induction by DEAE
or Carboxy-methyl sepharose (Pharmacia). Two-dimensional electrophoresis shows that the
lower band has a similar pI (around neutral) to the upper band, thus explaining the inability to
obtain a better purification with DEAE or CM sepharose. Cibacron blue resins as well as
several other dye resins, aminohexyl, polylysine, hydroxyapatite, and phenyl sepharose
resins were all tried on a small scale. Polylysine separation, when scaled up, gave
irreproducible results. Phenyl sepharose bound both proteins quite well in 0.4 M ammonium
sulfate, but elution in a 0.4-->0 M ammonium sulfate gradient (containing 10 mM KH2PO4, pH
7.5) seemed to elute out the contaminating protein at a specific point in the gradient, whereas
the 25 kD band eluted out over a broad range of concentrations both before and after the elution
of the contaminating band. Heat denaturation experiments demonstrated the temperature
sensitivity of ORF221 and the resistance of the lower band to thermal denaturation at >550 C
and thus could not be used as a method of purification.
At this stage, kinetic constants for the G-75 purified ORF221 were determined and a GST
fusion protein synthesized to try to circumvent the purification problem (the GST-ORF221
protein was cloned by a coworker). In the presence of 2mM Mn 2+, the Km was determined to be
2.8 mM +/- 0.20, and Kcat was 16.36 sec-1. X phosphatase exhibited a high specific activity
toward pNPP (38.91 +/- 2.22 pmol/min/mg) (Table II). Similar results were obtained with the
GST fusion protein (data not shown).
During the time in which we began working on the coupled assay system for determination
of kinetic parameters using a peptide substrate (according to the method of Etzkorn et al.,1994)
before beginning mutational studies, several papers were published which addressed precisely
this issue as it pertains to pNPP catalysis.
In an earlier paper (missed by our literature searches), Zhuo et al. (1993) had expressed
this X phosphatase under a T7 promoter in BL21-DE3 bacteria, and purified it to apparent
homogeneity with gel filtration chromatography and phenyl sepharose hydrophobic
interaction chromatography (cell extracts were loaded in 0.5M NaCl, and eluted in 0 M NaCl).
They assayed for activity using pNPP, full length serine-phosphorylated casein and tyrosine-
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Amount of
Approximate
specific activity Purification Yield
Purification step protein (mgs) (pLmol/min/mg) (x-fold) (%)
crude extract 50.3 19 1 100
0-60% (NH4)2 SO4  49.8 -- -- 99
G-75 gel filtration 24.6 37 1.94 49
Table I. partial purification of ORF221/, phosphatase. Activity was assessed at a concentration of 0.2
mg/ml of induction protein and high substrate concentrations (20 mM pNPP) in the presence of 2 mM
MnC12.
Enzyme Metal Stte Km Kt K•at/KmK Vmax Sp. act.
(mM) (sec-1) (M-1sec-1) (Msec-1) ymol/min/mg
ORF221 Mn 2+  pNPP 2.82 mM+/-0.20 16.36 5.8x103  1.30x10 -7  38.91+/-2.22
Table II. Kinetic parameters of ORF221: pNPP phosphatase assay in the presence of 2mM MnC12 and 7.9 nM
enzyme.
phosphorylated casein and their respective shorter peptides, as well as histidine-
phosphorylatedproteins and a phosphotyrosyl peptide deriving from the substrate of the
insulin receptor kinase as substrates. They report that protamine has no effect on the X PPase;
neither do other polylysines, or trifluoperazine (a calmodulin-binding inhibitor). They
demonstrate that Mn 2+ and Ni2+ stimulate the activity of the enzyme at 200 pmolar
concentrations; among the many divalent and trivalent cationic metals tested, they show that
the Mn 2+ activity is almost comlpletely inhibited by an equimolar amount of Zn2+ or Cu2+.
Activity is also inhibited by NaF, a noncompetitive PPase inhibitor (Ingebritsen and Cohen,
1983). As has been reported with other ser/thr phosphatases, phosphoserine and
phosphothreonine are not good inhibitors of Mn 2+- stimulated pNPPase activity;
phosphothreonine displays no inhibition whatsoever at 25 mM, and phosphoserine and
phosphotyrosine inhibit this PPase activity at 90 mM or not at all at 20 mM, respectively.
In terms of kinetic characterization of the enzyme using the aformentioned substrates, the
authors report a Km of 7.62 mM for pNPP in the presence of Mn 2+, a Kcat of 930 sec-1, and a
Kcat/Km of 0.12 tM-1 sec-l. These values indicate a lower level of efficiency than the values
we obtained for the Kcat/Km of OR221 of .058 iM-lsec-1; in our study as well, the enzyme
seemed to have a higher affinity for pNPP (i.e., a three-fold lower Km) than did that of Zhuo
et al. In their further characterization of the wild type enzyme, they found that the enzyme
exhibits a preference toward phosphoserine in 32p- labeled casein over phosphotyrosine,
reflected in both tighter binding and faster maximal velocity, the opposite preference is
established when the kinetic parameters relating to the Ser- and Tyr-phosphopeptides
derived from casein. The enzyme binds each peptide equally well but has a 6-fold higher Kcat
for the phosphotyrosine peptide than the phosphoserine peptide. Dephosphorylation of the
phosphohistidyl substrates NRII and Che A were also detected by autoradiograph of SDS
PAGE gels containing the products of the dephosphorylation reaction.
Several months later a second paper reporting the purification and characterization of
ORF221 appeared which described two mutations as well. The author demonstrates that
okadaic acid, a PP1 and PP2A inhibitor, was not inhibitory to the enzyme even to
concentrations of 1 pM (i.e. that used to inhibit PP1 activity completely-- PP2A is ten-fold
more sensitive). Inhibitor 1 and inhibitor 2, proteins which inhibit PP1 activity, also had no
effect on X PPase activity. No tyrosine phosphatase activity is detected using Raytide
(Oncogene Science) or CAMK II peptide (sequence:RRREEETEEE), as well as phosphorylated
EGFR, as substrates. In this paper, the author made two (gross) mutations--one involved
deletion of conserved residues 73-77, corresponding to a RGNHE stretch in the wild type
protein, while the other involved a Cysl38-->Phe or Ala mutation. All three types of
mutations reduce phosphatase activity toward pNPP to less than 5% of wild type phosphatase
activity. These mutations show that the wild type 25-26 kD protein cloned was indeed
responsible for the phosphatase activity attributed to it, but in general these mutations are
gross mutations which probably reflect changes in conformation of the protein away from a
conformation conducive to catalysis rather than necessarily implying a direct role in catalysis
for any of these mutated residues.
In a follow-up study, Zhuo et al. present their findings regarding several point mutations of
residues in X phosphatase which are conserved in other PP1, PP2A, and PP2B subunits and
determine their effects on metal binding, substrate binding, and catalysis. They mutate two
amino acids in the first homologous region, D20N and H22N; four amino acids in the second
major homologous region, D49N, D52N, R53A, andD59Q; and three in the third major
homologous region, R73A, H76N and E77Q. The Km of Mn 2+, Km of substrate binding, and Kcat
or specific activity were determined for the mutant PPases, using the substrate pNPP.
The study shows that D20, H22, D49, H76, and E77 are all involved in metal binding:
mutations in these residues give rise to >10-fold increases in Km values for Mn 2+ binding. All of
these mutants are characterized by quite low values of Kcat as well, except for the E77Q mutant
which, though its metal binding capacity is greatly perturbed (beyond that of the other
mutants), the Kcat is much higher than that of the other mutants, by at least 100-fold. This
would seem to indicate an important role for E77 in the actual binding of the metal, but a much
less important role in catalysis. Mutants D52N and E59Q induce a 40-fold and 10-fold reduction
in activity, respectively, although the Km s for Mn 2+ and pNPP are similar to wild type; the
conclusions to be drawn from this are unclear (the mutation could affect the accessibility of the
metal to the substrate binding site by blocking it sterically while not compromising the binding
of each, or may be important for water binding rather than metal binding, for example).
The R53A and R73A were tested in a pNPPase assay in the presence of either Ni2+
stimulation or Mn 2+ stimulation. In the wild type enzyme, Mn 2+ binds >40-fold more tightly
than Ni2+. In the R53A mutant, the Mn 2+ activity shows no major perturbation of either the
metal or substrate binding, and yet the specific activity is reduced drasticly; the Ni2+ activity,
however, shows a 20-fold increase in the Km of pNPP as well as a drastic reduction in specific
activity. The R73A mutant is characterized by a slightly tighter metal binding capability and
a less drastic reduction in specific activity than that of the R53A mutant; assays in Ni2+
showed a similar ability to bind Ni2+ as compared with wild type enzyme, a slightly weaker
binding of pNPP, and a less drastic reduction in specific activity as well. IC50 's for inorganic
phosphate inhibiting the pNPP reaction are all raised significantly over wild type values,
indicating along with the pNPP Km data for the Ni2+ activity that Arg53 and Arg73 are both
critical for substrate and phosphate binding (these effects seem metal-dependent- the Mn 2+
activity seems to be much less affected by these mutations--which point to possible
conformational differences at the active site based on the stimulatory metal used).
It will be interesting to see continued mutational analysis of the ORF221 to identify
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residues important for substrate binding- whether for pNPP binding or peptide substrate
binding- and to apply these studies to other protein phosphatases with significant homology to
ORF221. Recently the catalytic subunit of human PP1 has been cocrystallized with an
inhibitor, microcystin LR, and the crystals obtained diffract to 2.8 angstroms (Barford and
Keller, 1994). With a crystal structure in hand, the current understanding of the mechanism of
catalysis and the architecture of the substrate-and/or inhibitor- binding cavity will be greatly
enhanced.
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CHAPTER 2
Structure/Function Studies of Calcineurin
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PP2B, or calcineurin, was originally discovered as an inhibitory protein in mammalian
brain which inactivated a Ca 2+-dependent cyclic nucleotide phosphodiesterase (Sharma and
Kalra, 1994). Several years later the enzyme was identified as PP2B, a protein phosphatase
which had already been purified previoulsy (Stewart et al., 1982). Calcineurin is a
heterodimer of the A (catalytic, 61kD) and B (regulatory, 19kD) subunits (reviewed in Ballou
and Fischer, 1986). The regulatory subunit binds four moles of calcium, one in each of four EF-
hand domains characteristic of other calcium-binding proteins such as calmodulin (Klee et al.,
1979). The A subunit contains a N-terminal catalytic domain which shares a high degree of
homology to PP1 and PP2A (see Chapter 1, figure 1), followed by a putative calcineurin B
(CNB) binding domain. C-terminal to the CNB binding domain is a calmodulin binding
domain, followed by an autoinhibitory domain (Kincaid, R.L., 1993). Calcineurin acts as a
calcium sensor in the cell, undergoing a gain in function upon increases in intracellular free
calcium and subsequent binding of calcium to the CNB calcium binding sites; at these raised
levels of Ca2+, calmodulin binds the AB heterodimer with nanomolar affinity (Klee et al.,
1979; Hubbard and Klee, 1987). These subunit changes effect a conformational change which
activates the phosphatase activity of calcineurin toward its substrates. Tightly bound Fe3+
and Zn2+ ions have been detected in native bovine brain enzyme (King and Huang, 1984),
suggesting that calcineurin is a metalloenzyme.
Calcineurin has a wide tissue distribution in mammals; it has been detected at high levels
in brain and testes, as well as in skeletal muscle, kidney, heart, ovary, spleen, and thymus
(reviewed in Ballou and Fischer, 1986; Kincaid et al, 1990). Multiple genes which encode both
the A and B subunits have been identified, each in turn giving rise to several different
spliceoforms.
Proteolytic digestion studies aimed at mapping the different functionalities implicit in
native bovine brain calcineurin have contributed much to our understanding of the domain
substructure of the catalytic subunit. Proteolysis studies led Hubbard and Klee (1989) to
identify an autoinhibitory domain distinct from the inhibitory effects of the calmodulin
domain. Digestion of the CNA/B heterodimer with clostripain (which hydrolyzes proteins at
arginine residues) yields different molecular weight fragments, depending on the absence or
presence of calmodulin. Aliquots of the proteolysis reaction taken at several time points were
characterized by SDS-PAGE gels after gel filtration and assayed for their ability to bind
calmodulin, as well as for their pNPP phosphatase activity. Clostripain proteolysis in the
absence of CAM quickly resulted in the disappearance of full length CN and concommitant loss
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of CAM binding by any of the larger proteolytic fragments present. Simultaneously, a 43 kD
proteolytic fragment was generated which still contained bound CNB, and which was
characterized by Ca2+-dependent, CAM-independent pNPPase activity (measured in the
presence of Mg 2+) at levels 30-40-fold higher than the activity of the native enzyme tested
under similar conditions. The Ca 2+-independent activity of the 43 kD fragment was slightly
less than 10-fold higher than the activity of the full length enzyme in the absence of Ca2+.
Several minutes later, a 40 kD fragment, still containing bound CNB, appeared which was
characterized by lack of phosphatase activity toward pNPP. In similar proteolysis
experiments performed in the presence of calmodulin, a different set of proteolytic digestion
species were generated. At first, a 57 kD fragment appeared during the first 10 minutes of
digestion which was competent to bind calmodulin, and which contained a virtually Ca2+-
CAM independent activity, corresponding to a 10-fold increase in pNPPase activity over that
of the native enzyme. Further proteolytic digestion yielded 55 kD, 42 kD, and 14 kD fragments
which proved to be catalytically inactive against pNPP as a substrate whether or not Ca2+
was present. The 55 kD and 14kD species did retain the ability to bind to calmodulin. N-
terminal sequencing of the discreet proteolytic forms generated show that like the 61 kD
native enzyme, the 57 kD and 43 kD enzymes were blocked toward Edman degradation, unlike
the 55, 42, and 14 kD fragments which yielded some sequence information. The authors propose,
on the basis of these experiments and others done previously by other colleagues, a functional
mapping of native calcineurin. They assert that the protein contains an N- terminal catalytic
domain, followed by a CNB binding domain, a calmodulin binding domain, and an
autoinhibitory domain at the extreme C- terminus of CNA (see Hubbard and Klee, 1989, and
references therein). The 43 kD protein, a form generated by proteolysis in the presence of CAM
but which itself no longer binds CAM, exhibits a 3-4 -fold increase in Ca2+-dependent activity
compared to the 57 kD fragment and Ca2+ -independent activity which is similar to the
Ca 2+/CAM stimulated activity of the 57 kD fragment. Given this extra stimulation of the 43
kD fragment toward pNPP when compared with the 57 kD enzyme, as well as the 30-40 fold
increase in pNPPase activity relative to the native bovine brain enzyme, the authors predict
the existence of an autoinhibitory domain which is separate from the calmodulin binding
domain. The activity of the 57 kD fragment represents the level of stimulation achieved upon
ablation of the autoinhibitory domain. The activity of the 43 kD protein, corresponding to a
protein lacking both part or most of the calmodulin binding domain and the autoinhibitory
domain C-terminal to it, displays an even higher level of activity than would be attributable
to merely the lack of a functional autoinhibitory domain. These findings suggest that the
calmodulin binding domain itself mediates a detectable level of inhibition distinct from that of
the autoinhibitory domain, and that the Ca2+ stimulation of the 43 kD fragment most probably
results from effects mediated by the CNB protein which remains bound to the 43 kD protein
(Hubbard and Klee, 1989).
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Currently three mammalian genes have been cloned which encode calcineurin, with most of
the heterogeneity occuring in the N- and C-termini of these genes. The a ( Muramatsu et al.,
1993) and 0 (Muramatsu et al., 1992) genes have been cloned from brain tissue (displaying >80%
identity among the three proteins), while the y gene has been cloned from testes (Muramatsu
and Kincaid, 1992). Each of these genes generate several different isoforms, purportedly
arising from alternate splicing of mRNA. Differences in substrate specificity and tissue
distribution of these isoforms and spliceoforms will be key to understanding the role of
calcineurin in very different cellular processes which are potentially occuring within any one
given cell. The human full length cDNA for CNAal has been cloned (Muramatsu and Kincaid,
1993) from a hippocampal cDNA library, encoding a protein which differs from the mouse
CNAal by only two amino acids, and which shows 90% identity in the upstream 5'
untranslated region to that of the mouse cDNA. Comparison of the al, [2, and y2 sequences
show 100% homology in the putative CNB binding domain, only one or two conservative
changes in the calmodulin-binding domain, and 1-2 conservative replacements plus one variant
residue in the putative autoinhibitory domain (Muramatsu and Kincaid, 1993). In an earlier
paper, Kincaid et al. (1990) compare murine and human CNA clones they obtained from
cerebellum libraries of the respective organisms. In several of the clones, an in-frame deletion
of 30 base pairs was detected, located between the calmodulin (CAM) binding domain and the
autoinhibitory domain. This sequence corresponds to the CNAa2 sequence, which is similar to
the Y2 isoform in that both isoforms are characterized by this 10- amino acid deletion. The [
isoform is distinct in its N-terminal polyproline sequence, suggestive of possible interaction
with SH3 domains (which bind proline-rich sequences) as a mode of targetting or regulation of
activity (Saksela et al., 1995; Viguera et al., 1994). Differences in the primary sequence such as
these, as well as the many others at the N- and C-termini of the a, 0, and y isoforms, could
mediate changes in substrate specificity, targeting, or regulatory control of phosphatase
activity.
Multiple genes encoding CNA and CNB have been identified in other organisms as well,
including and S. Cerevisiae,Neurospora Crassa, and Drosophila. The PP2B genes discovered in
S. Cerevisiae were discovered by 125I-labeled calmodulin screening of a yeast expression
library followed by CNA hybridization experiments with CAM-binding positive clones.
Sequencing of these two clones show some differences between the yeast and human genes upon
inspection of sequence alignments of yeast CNA1 and CNA2 alongside human CNAal. The
yeast CNA1 clone contains a 55-bp N-terminal extension, while the CNA2 clone contains a
shorter 29-bp N-terminal extension. The CNA1 and CNA2 sequences contain only about 54%
identity with human CNAa (as opposed to the murine >99% identity), indicating a separate
evolutionary origin for the two yeast genes. There are several nonconservative changes within
the putative CNB and CAM binding domains and autoinhibitory domains, as well one deletion
(relative to CNAal) directly N-terminal to the autoinhibitory domain (which encompasses
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but is also twice as large as the deletion in a similar area found for the human y2 and a2
isoforms). There are also several insertions present in the yeast genes. One of them intervenes
at a point in the protein N-terminal to regions where lambda phosphatase, PP1, PP2A, and
CNAa exhibit several identical or conserved residues; the other insertion is located between
the CNB- and CAM- binding domains. Phenotypically, cnal and cna2 single mutants and
cnal/cna2 double mutants seemed to possess no other irregularities other than a two- fold, or
four-fold, reduction in ability of such mutants which are Mata at the mating locus to overcome
a factor-induced growth arrest, as determined by halo size surrounding an a factor-treated disc
placed on a lawn of yeast cells (Cyert et al., 1991).
A sequence homologous to the human calcineurin A subunit was likewise found in
Neurospora Crassa (Higuchi et al., 1991), which seems more closely related to mammalian
CNA sequences than to the yeast CNA1 and CNA2. Using a mouse CNAa clone to identify N.
Crassa clones from a cDNA library by plaque hybridization techniques, a homologous open
reading frame, "Norfl," was found which displays 62% identity to the mouse CNAa gene. The
Norfl gene contains inserts (relative to the human sequence) between the CNB and CAM
binding domain, as well as both before and after the autoinhibitory domain. The
autoinhibitory domain itself contains quite a few nonconservative residue changes (unlike the
well-conserved CNB- and CAM-binding domains of Norfl). Recombinant Norfl protein was
purified by CAM-sepharose chromatography, and pNPP phosphatase activity was assayed
for in both the absence and presence of Mn2+, CAM, and/or CNB which had been purified from
bovine brain. Norfl displays twice as much Mn2+/Ca2+ -stimulated activity as the CAM-
sepharose purified bovine brain CN used in their assay, although the opposite results are
obtained in Mg 2+/Ca2+ basal activity measurements. Regarding dephosphorylation of protein
substrates in the presence of Mn 2+, Mg 2+, and Ca2+, bovine CN was 10-fold more active in
inhibitor-1 dephosphorylation, whereas levels of casein and histone H1 dephosphorylation
were found to be comparable for Norfl and bovine brain CN. Reconstitution of Norfl with
bovine brain CNB caused no change in pNPP hydrolysis, seeming to imply that the role of CNB
in Norfl activity was greatly reduced from that of mammalian calcineurin. The effects of CNB
on Norfl-catalyzed dephosphorylation of protein or peptide substrates was not examined in
this study (Higuchi et al., 1991).[Studies undertaken in a different lab comparing the effects of
Norfl reconstitution with CNBP1 from brain vs. CNB02 from testes actually show that while
both p1 and $2 (each with his-tags for purification purposes) form heterodimers with Norfl, p1
is much more effective at stimulating the activity of Norfl toward pNPP than $2 is. Such
results support the notion of the existence of conformational differences and perhaps subtle
changes in substrate specificity depending on the combination of A and B subunits present. (Ueki
and Kincaid, 1992)].
Consistently, the regions between the putative CNB binding domain and the CAM binding
domain have a much higher degree of heterogeneity than other parts of calcineurin, both
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within species, as in comparing isoforms and spliceoforms, as well as across other species. The
second CNA subunit found in drosophila is no different: it contains a 27-amino acid insert,
including an acidic set of residues followed by a stretch of 7 asparagines in a row, 13 amino acids
later. This drosophila gene has a deletion of several residues immediately N-terminal of the
autoinhibitory domain, which itself has several non-conservative changes relative to
mammalian (rat) CNA a and P isoforms. While the drosophila enzyme exhibits 73% identity
with mammalian a and 0 isoforms at the protein level overall and about 65% at the nucleotide
level, the drosophila calcineurin also contains a 34-amino acid C-terminal extension, continuing
a sequence which contains a noticeably large amount of serine and threonine residues.
Studies on the interaction between CNA, CNB, and CAM using recombinant subunits, either
coexpressed or reconstituted, have contributed a great deal toward our understanding of the C-
terminal functions of the calcineurin A. Perrino et al. (1992) assessed the single contributions of
CNB and CAM toward the pNPPase and RII peptide phophatase activity of a recombinant
CNAo(2 expressed in Sf9 cells in a baculoviral system. Upon reconstitution of the recombinant
CNAa2 with bovine brain CNB (l1 isoform) in the presence of Mn 2+ and absence of Ca2+, the
activity of the enzyme against 32P-labeled RII peptide in the presence of Mn 2+/CAM was found
to be similar to that of bovine brain-purified CNAal/CNBpl holoenzyme ( 667 nmol/min/mg
vs. 410 nmol/min/mg). Both Mn 2+/CAM and Mn 2+/CNB stimulated the basal CNA RII -
peptide phosphatase by 4-fold and 6-fold, respectively (Mn 2+/CAM stimulated native bovine
brain CN by 5-fold). A synergistic 86-fold activation of CNAa2 to 667 nmol/min/mg was
obtained after reconstitution with CNB and incubation with calmodulin. Analysis of the
kinetic parameters of these enzymes revealed that the calmodulin stimulation of the RII
phosphatase activity of both the CNA or CNA/B enzymes was mediated by a change in Vmax
rather than Km. Interestingly, the effects of CNB upon the activity of the catalytic subunit
manifested themselves by a lowering of Km in the A/B dimer relative to the Km of the A
subunit, as well as a small change in Vmax. Regarding pNPP hydrolysis, reconstitution of the
recombinant CNA with bovine brain CNB had no effect on specific activity, although
subsequent CAM stimulation was much higher for the calcineurin A/B heterodimer than for the
single CNA subunit. These results indicate that while calmodulin binding may function mainly
by relieving the enzyme of autoinhibition and not by changing the conformation of the active
site itself, the B subunit exerts its influence mainly by effecting such a conformational change as
would allow the enzyme to bind its RII peptide substrate with higher affinity.
The predicted CNB binding domain of the catalytic subunit has been extremely well
conserved from yeast to human (and perfectly conserved from drosophila to human). In a recent
paper, residues 328-390 from the CNAa2 isoform, expressed as a GST fusion protein, were
competent to bind to rat brain myristoylated CNB when incubated in the presence of Ca2+ or
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Mn2+. The fusion protein was also shown to reduce the activity of wild type CNA/CNB
reconstitution, presumably by competing for CNB, in a concentration-dependent manner. In
several point mutations where hydrophobic residues were mutated to either acidic or
uncharged residues (at Va1349, Phe350, Phe356, and Val357). These mutations greatly reduced
the hydrophobicity of the CNB binding domain greatly and the mutant fusion proteins were
found to be unable to bind CNB. (The interaction between wild type CNA and CNB, once the
heterodimer has been formed, has been known to rely on hydrophobic contacts which are
disrupted only in conditions as strong as 6M urea-Merat et al, 1985). The mutants showed
slightly higher Mn2+/CAM -stimulated phosphatase levels against phosphorylated RII
substrate than did the wild type (pointing to relative conformational integrity). Yet, upon the
addition of CNB, these mutants exhibited less than 10% of the fully stimulated wild type
activity treated similarly. These studies further establish the importance of calcineurin B
interactions with and regulation of the catalytic subunit to yield a conformationally efficient
phosphatase (Watanabe et al., 1995).
In a recent study, investigators characterized the phosphatase activity of two C-terminal
truncation mutants of the CNAcX2 (or CNAaS) enzyme: CNA457 (denoting a C-terminal
truncation starting after residue 457) and CNA420. CNA/B heterodimers obtained by
coexpression in Sf9 cells using the baculovirus system and containing a mixture of non-
myristoylated and myristoylated CNB subunits, were assayed for Mg2+-stimulated 32P-RII
activity in the absence and presence of Ca 2+/CAM. This study found the A457 mutant to be
partially Ca2+-independent, and the A420 mutant to be "completely" Ca 2+ -independent. They
find that the wild type, A457, and A420 mutant heterodimers display a similar sensitivity of
the Km of RII phosphopeptide toward Ca2+. All three enzymes show a 4-5-fold reduction in Km
upon the inclusion of Ca2+ in the assay buffer, from about 110 pmolar to around 26 pmolar for all
three. When the A420 enzyme was expressed alone and assayed in the absence of CNB and
presence of Ca2+ and/or CAM, the measured Km is close to 110 pmolar- implying that the
Ca 2+-induced tighter binding of the RII peptide substrate is mediated by a conformational
change in the A subunit effected by CNB calcium binding. Without CNB, the wild type and
A420 enzymes are characterized by very low phosphatase activity. However, in the presence
of CNB, Ca2+, and CAM, the A420 mutant and A457 mutant (which both still possess
calmodulin binding domains) display even greater specific activity toward phospo-RII peptide
than the wild type enzyme. This high specific activity is mostly Ca2+- and CAM -independent
for the A420 mutant, and partially Ca2+/CAM-independent for the A457 mutant. According to
this study, then, the specific activity (and thus the Kcat) of the A420 mutant is independent of
Ca2+,while the Km is Ca2+-dependent, (Perrino et al., 1995).
Aside from the internal regulatory functions of the CNB subunit, the catalytic subunit has
been shown to undergo phosphorylation at a residue located within the CAM-binding domain.
Native calcineurin has been found to contain up to 0.6 mol phosphate/mol calcineurin (King and
Huang, 1984), so the suggestion that phosphorylation of PP2B regulates its function in vivo may
be entertained as a distinct possibility. In vitro phosphorylation of calcineurin by a
Ca2+/CAM independent form of CAM kinasell (CAMKII), an enzyme abundant in neural tissue,
results in rapid incorporation of 0.8 mol 32P/mol calcineurin (Hashimoto et al., 1988).
Phosphorylation catalyzed by protein kinase C (PKC) has been observed to take place rapidly
as well, to a stoichiometry of 1 mol 32P/mol calcineurin (Hashimoto and Soderling, 1989). In
two independently confirmed reports (Hashimoto et al., 1989; Martensen et al., 1989), the
phosphorylation site for both CAMKII and PKC was found to correspond to residue 411 in the
CNAal sequence, which lies just within the C-terminal edge of the putative CAM binding
domain. Ca2+ was required for phosphorylation of calcineurin but not for phosphorylation of
other substrates by PKC or CAMKII, implying that the Ca2+ played an essentially substrate-
directed role, i.e. phosphorylation could only occur upon realization of a calcium-induced
conformational change, most probably due to CNB calcium binding. Addition of CAM to the
kinase buffer inhibited the phosphorylation, although once phosphorylated, calmodulin was
still able to stimulate phosphatase activity toward pNPP or myosin light chain substrates.
Hashimoto et al. (1988) found, additionally, that the phosphorylation affected both Vmax and
Km values of the enzyme, depending on the substrate. For the phosphorylated calcineurin, the
Km for mysosin light chain was two-fold higher than the value of the unphosphorylated form,
although the Vmax remained similar for both forms. Regarding the kinetic parameters of
pNPP hydrolysis, although the Km values for the two forms were similar, the
unphosphorylated enzyme's specific activity was two-fold higher than that of
phosphorylated calcineurin. In any case, it seems that this phosphorylation causes a
downregulation of phosphatase activity. There is evidence for in vitro Ca2+-dependent
dephosphorylation of the CAMKII/PKC phosphorylation site by both PP1 and, more
efficiently, PP2A, which provides the possibility of a mechanism for the return of calcineurin
to the unphosphorylated state as well (Hashimoto et al., 1988). In vivo data regarding this
phosphorylation/regulation issue and/or identification of the actual phosphorylation site(s)
corresponding to the detected levels of native phosphorylation have not yet been presented.
The immunosuppressants Cyclosporin A (CsA) and FK506 (Tacrolimus) have been found to
bind and inhibit calcineurin's protein phosphatase activity by first binding to endogenous
cyclophilins (CyP A, B, or C; in the case of CsA) or FKBPs (FK506 binding proteins) in the cell
and then presenting a complex inhibitory surface to calcineurin (Liu et al., 1991). This
interaction has been probed with multiple techniques, ranging from affinity chromatography
(Liu et al., 1991) to chemical crosslinking experiments (Li and Handschumacher, 1993; Husi et
al., 1994), photoaffinity labeling (Husi et al., 1994), proteolysis experiments (Swanson et al.,
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1992), recombinant calcineurin truncations and point mutant experiments (Etzkorn et al., 1994;
Parsons et al., 1994; Clipstone et al., 1994), andthe yeast two-hybrid system (Clipstone et al.,
1994). Drug-inhibited complexes were originally detected by calcium-dependent binding of
CNA/CNB/CAM to a GST-FKBP fusion protein immobilized on glutathione Separose 4B resin
charged with FK506 drug. This complex could be competed off of the resin only with
cotreatment of FK506/FKBP or CsA/CyPA but not with treatment of rapamycin/FKBP
(rapamycin is an immunosuppressant which binds FKBP as well, but has been found to inhibit
the G1-S transition rather than the CsA/CyP-sensitive Go-Gi transition-reviewed in Schreiber
et al., 1993; Schreiber et al., 1992; and Sigal and Dumont, 1992). CNA/CNB heterodimers
treated with the drug-immunophilin complexes (300nM FK506 and 2.3 pM FKBP) in the
presence of Ca2+ and calmodulin showed inhibited phopho-RII dephosphorylation (Liu et. al,
1991), while possessing, at the same time, a 4-fold increase in pNPP phosphatase activity (at
concentrations of 10 pM CsA + 10 pM CyPA [Swanson et al., 1992], i.e. well above the Ki of 270
nM drug/immunophilin complex; Etzkorn et al., 1994).
Further experiments disecting this drug/immunophilin/calcineurin interaction have
attempted to pinpoint the minimal residues and domains of the holoenzyme required for
inhibition by the drug/immunophilin complexes. Reciprocal plots of 1/v vs.1/s have shown
that the mode of inhibition with the wild type calcineurin and CsA/wild type CyPA is
noncompetitive. In the same study, several point mutations in CyPA had been made, in efforts
to better understand which residues are important for creating this interaction. The R69E
mutant was found to exhibit 13-fold lower inhibition of phosphatase activity with an
apparent Ki of 3400 nM, while the intrinsic peptidyl-prolyl cis-trans isomerase activity of
this CyPA mutant was comparable to wild type (Etzkorn et al., 1994). Li and Handschumacher
(1993), in chemical crosslinking experiments, detected crosslinking of CsA to CNB in the
presence of 1 mM CaCl2/1 mM MgCl2/1 mM MnSO4. They found higher levels of crosslinking
upon the addition of calmodulin. In the presence of 2mM EGTA no such complex is detected, in
agreement with previous findings as to the Ca 2+-dependency of the drug/immunophilin
interaction with calcineurin (Liu et al., 1991). Limited proteolysis of native calcineurin
yielded a C-terminal truncation enzyme which was characterized by a Ca2+-independent
crosslinking of CNB to cyclosporin/ cyclophilin complexes (Swanson et al., 1992; Li and
Handschumacher, 1993). Husi et al. (1994) reproduced earlier results showing the essential
role that CNA plays in the crosslinking of CNB to CsA/CyP and FK506/FKBP complexes, as
well as the essential role of Ca2+(but not CAM) in creating the wild type complex between
calcineurin and the drug/immunophilin. Importantly, they were able to show, by covalent
attachment of a photoaffinity label to CsA, the Ca2+-dependent labelling of both the CNB
subunit as well as the CNA subunit in the presence of CAM. These results implied, for the first
time, that the CNA subunit makes direct contacts with the drug/immunophillin complex as
well as the CNB subunit (Husi et al., 1994). Purified reconstituted CNA/CNB heterodimers of
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CNAal C-terminal deletion mutants showed different abilities to bind drug/immunophilin in
thepresence and absence of calcium. While a recombinant CN containing a truncation just C-
terminal to the putative autoinhibitory domain bound FK506/FKBP/GST beads in a Ca2+-
dependent fashion, the autoinhibitory deletion mutant and the mutant with a C- terminal
deletion up to and including the CAM domain bound the drug complex just as well as the native
enzyme in the presence of Ca 2+ , clarifying the results of the proteolysis experiments mentioned
earlier. Clipstone et al. (1994) found that a truncation of calcineurin corresponding to residues
99-394 of CNAal was competent to bind CNB in vivo as judged by immunoprecipitation with
anti-CNB antibodies (as was a C-terminal truncation to residue 376), yet was unable to bind
drug/immunophilin complexes immobilized on a GST column as described above. A 32-394
mutant was able to bind CNB and both CsA/CyPA and FK506/FKBP. These results indicate
possible involvement of CNA in making contacts to the drug/immunophilin complex (although
the possiblity exists that the 99-394 mutant is improperly folded and therefore unable to bind
the complex). This group also used yeast two-hybrid technology to probe the requirement for
CNB in drug/immunophilin binding in vivo. A his3 mutant yeast strain carrying a plasmid
containing a C-terminal truncation to residue 394 fusedto a GAL4 activation domain and a HIS3
gene under the control of a GAL4 promoter, transformed with a plasmid carrying FKBP fused to
the GALA DNA binding domain was able to grow on plates containing FK506 and lacking his.
No FK506-dependent growth was observed for the 394 mutant with the endogenous yeast CNB
gene disrupted. Similarly, a 332 mutant (with C-terminal truncation up to residue 332, i.e. a
mutant which does not contain the proposed CNB binding domain) transformed with GAL4-
FKBP also does not grow on FK506-containing selective media, pointing toward the important
contribution of the B subunit toward in vivo inhibition of calcineurin by FK506/FKBP.
In the current study, we created several GST fusion-deletion mutants of calcineurin A, A311,
A332, and A376. Each of these has a fully intact catalytic domain, as determined from
homology to X phosphatase and PP1/PP2A; only A376 still contains a CNB binding domain.
Activity of these clones was assessed using pNPP and RII phosphopeptide as substrates.
Materials and methods
Cloning of Calcineurin truncation mutants. Human Calcineurin A a (CNAa) template was a
generous gift of Dr. Randall Kincaid; this template had one silent mutation. Three truncation
mutants were studied: A311 (amino acids 1-->311 of the full length calcineurin), A332, and
A378, all as fusion proteins to glutathione S-transferase . PCR primers (Bio-Synthesis) were
designed such that the 5' primer contains a BamH1 site immediately 5' of the CNAa coding
sequence, while the 3' primers contain a HindIII site immediately downstream of a stop codon
which follows the coding sequence. The 3' primer for the A 378 clone contains an XhoI site
between the HindIII site and the stop codon to facilitate the cloning of a tandemly expressed
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CNB subunit (with 5' XhoI and 3' HindIII restriction sites) in future studies of coexpressed A378
and CNB. The primer sequences were as follows: 3'primer for A311 (CN37T51): 5'-AGCTAC
AAGCTT TCATTGGGCTTCGTGGGCTC-3'; 3' primer for A332 (CN38T52): 5'-AGTCAC
AAGCTT TCAGATATTCATAACATTGTTC-3'; 3' primer for A378 (CN39T53): 5'-
AGCTACAAGCTTCTCGAG TCACCCTAGTTCATCATCTGA-3'; 5' primer for all three clones
(CN34T48): 5'-ATCGCGGATCCCATATGTCCGAGCCCAAGGCA- 3'. Truncation mutants were
created and amplified by PCR. PCR reactions for all three clones included 2mM MgC12, 1pM
each of 5' and 3' primers, and 20 ng of CNAa template per 100 il reaction (PCR reagents were
from Perkin-Elmer). A332 and A378 were amplified by the following method: 960C, 6' -one
cycle; 960C, 1'/ 450C, 1'/ 720C,1.5'-three cycles; 940C, 1'/ 450C, 1'/ 720C, 1.5'-thirty
cycles; 720C, 6'/ 250C, 30'/ 40C, 999'-one cycle. A311 was amplified similarly except that the
annealing temperature was raised to 550 C in all thermal cycles. PCR products were restriction
digested with BamHI/HindIII as was the pGEX-KG plasmid. Restriction products were
purified by electrophoresis in a low- melt agarose gel at 40C (NuSieve GTG agarose, FMC
Bioproducts, Rockland, ME) and an in-gel ligation was conducted according to standard
procedures using T4 DNA ligase, at 160C, overnight. Ligation products were transformed into
competent DH5a cells. DNA from transformed bacteria were restriction-digested with the
appropriate enzymes to confirm presence of the clones; dideoxy sequencing was partially
completed for the A332 and A378 mutants. A378 was further transformed into competent XA90
E. Coli for expression.
Induction and Purification. Bacteria carrying the GSTfusion protein plasmid were
innoculated into 10-12 mls of LB broth containing 100 gg/ml ampicillin and grown at 370C
overnight with shaking. The next day, secondary cultures were grown by diluting the overnight
cultures 100-fold into 1 liter of LB containing ampicillin as before. Due to solubility
problems/inclusion bodies, the A378 mutant secondary culture was grown at 300oC, while the
A332 and A311 cultures were grown at 370C. A311 mutants were induced to 0.5mM IPTG
(Isopropyl 3-D-thiogalactopyranoside; Sigma) when the OD596 reached 0.6. A332 and A378
mutants were induced to 0.5 mM IPTG when the OD596 reached 0.9. A378 cultures were grown
for 4 hours after induction; A311 and A332 cultures were grown for 5-6 hours. The bacteria were
harvested by centrifugation at 8,000 x g for 10 minutes and washed in buffer A(75mM Tris,
120mM NaCI, 1mM EDTA, 1mM EGTA/ pH7.5). Pellets were weighed and resuspended in
buffer A+protease inhibitors (1pg/ml leupeptin, 1pg/ml pepstatin, 2 gg/ml aprotinin, and 1mM
PMSF) at 5 mls buffer/mg pellet. The cells were lysed by two passages in a French Press at
12,000 psi. Cell debris was removed by a further centriguation at 10,000 x g for 15 minutes. The
crude lysate was incubated with Glutathione-sepharose 4B beads (Pharmacia) which had
been preequilibrated with buffer A for 6 minutes at 40C, rotating. After binding and
centrifugation to retrieve the pellet, the pellet was washed four times with 12 volumes of
buffer A and then eluted for three hours at 40C, rotating, in buffer A containing protease
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inhibitors as before, with the addition of 0.75 mM DTT (Malincrodt) and 10 mM glutathione
(Sigma). Protein concentration of the eluted protein was measured by Bradford assay using
bovine serum albumin (Boerhinger Mannheim) as a standard. Purification was followed by
SDS-PAGE according to the method of Laemmeli). Due to the low concentration of protein in
the eluate, BSA dissolved in buffer A was added to a final concentration of 2-3mg/ml and
glycerol added to 30%. Proteins were stored at -200C. Typical yield of purified A378 was 0.45
mg of protein from one liter of cultures. The A332 mutant yielded 0.7 mgs, and the A311 mutant
yielded 0.3 mgs, from one liter of bacterial cultures.
Reconstitution of CNAa A378 mutant and CNB. Calcineurin B, cloned into a pAED4 vector
with a T7promotor and engineered to include a 5' NdeI site and3' PstI site, was transformed into
DH5a and sequenced by coworkers using the dideoxy DNA sequencing method. BL21-DE3
competent cells were transformed with pAED4-CNB. Transformant colonies were innoculated
into 10 mis of LB containing 100 ig/ml and grown overnight at 370C. Secondary cultures were
started by a 1/100 dilution of the over night culture into 1 liter of broth as before and grown to
an OD596 of 0.6, at which point the cultures were induced with 0.7 mM IPTG (final
concentration) for 5-6 hours. Cultures were harvested, washed, resuspended in buffer B (75 mM
Tris, 50mM NaCI, lmM EDTA, pH 7.5 ) containing protease inhibitors as before, and lysed.
After centrifugation at 10,000 x g for 15 minutes to remove cell debris, the crude lysate was
precleared by Glutathione-sepharose 4B beads preequilibrated in buffer B. The precleared
CNB lysate was next incubated with GST beads which had been freshly incubated with A378
crude lysate (also made using buffer B) and which had been washed once with buffer B after
A378 binding. The reconstitution buffer (B) included either 2mM Ca 2+ or 2 mM Mn 2+ . The
incubation was carried out for 3 hours on a rotator at 40C; the beads were then washed three
times in buffer B containing 300 mM NaCl. After one wash with buffer A, the proteins were
eluted for three hours in buffer A containing protease inhibitors, 10 mM glutathione, and 0.75
mM DTT. As before, purification was followed by SDS-PAGE and protein concentration
measured by Bradford assay, using BSA as the standard. To detect the presence of CNB,
Western blotting of the reconstituted protein was performed using al gg/ml dilution of CNB
monoclonal primary antibody.
Partial purification of purine ribonucleoside phosphorylase (PRPase). The bacterial
purine ribonucleoside phosphorylase preparation purchased from Sigma was approximately
30% pure judging by SDS-PAGE analysis of the crude enzyme preparation. The 29 kD enzyme
was further purified by Q sepharose chromatography (Pharmacia), essentially according to
the method of Etzkorn et al. (1994). Six milligrams of crude PRPase were loaded to a 10 ml bed
volume of Q sepharose in a 1.5x10cm Econo-Column (BioRad) equilibrated with 50mM Tris, pH
7.5 (at 40C). The column was developed with a linear gradient from 50mM Tris pH 7.5 (60 mls)
to 50 mM MES (2-[N-Morpholino]ethanesulfonic acid, Sigma), pH 5.8 containing 0.5M KCI (60
mis) at a flow rate of 1.1 ml/min. Fractions of 3.3 ml were collected; protein elution was
followed by OD280 and SDS-PAGE. Fractions containing a 29 kD species were tested for PRPase
activity using first crude, then purified MESG (methyl thioguanosine), and inorganic
phosphate as substrates. Active fractions were pooled and concentrated in a centricon-30
(Amicon); glycerol was added to 30% and the protein was stored at -200C. The
spectrophotometric assay for PRPase activity was performed in 1x buffer C ( 100 mM Tris, pH
7.6, 1 mg/ml BSA, 0.5 mM DTT) according to the method of Webb (1992). Briefly, in this assay,
conducted at ambient temperature, Pi concentrations ranged from 5->25 iM KH2PO4 and the
MESG concentration was kept constant at 50 pM. 5 gig of PRPase per ml reaction was added to 1x
buffer and preincubated for 2 minutes, at which point MESG was added to 50 IpM and the change
in absorbance at 360 nm monitored for 1 minute, or as long as the reaction remained linear. The
Km was found to be 15.6 pM for inorganic phosphate, similar to the reported 26 tiMolar Km;
Kcat= 4 .44 sec-1; Kcat/Km=5.79 x 106 M-1; specific activity= 9.2 pmol/min/mg purified PRPase.
MESG Synthesis and Purification. MESG (methylthioguanosine) was synthesized
essentially according to the method of Webb and Broom et. al from 2-amino-6-chloropurine
nucleoside (Sigma) by a coworker. In a modified purification procedure, crude MESG was
dissolved in 10 mgs/ml H20 and further purified by preparative HPLC on a Vydac C18 reverse-
phase employing an isocratic elution in 20 mM KOAc, pH5.5 containing 10% (v/v) methanol,
with peak detection set at 342 nm and a flow rate of 6.0 ml/min. Individual peaks were
collected and lyophilized, then resuspended in H20 to assess activity in the PRPase assay.
The active peaks from several runs were combined and lyophilized, and stored at -800C until
resuspended in H20 immediately prior to usage (and stored at -200C.) Since the Xmax was
found to be sensitive to pH, the OD at the Xmax for a range of pH's was measured in order to
correlate the extinction coefficient reported at pH 1 by Broom et.al. (1964) with the apparent
extinction coefficient and absorbance at pH 5.5. e 344 at pH 5.5 was found to be 2.18 x 104 M-1
cm-1. An estimated 40% (by weight) of the crude MESG was recovered after HPLC purification
which was active in the PRPase assay.
Phosphorylation and purification of phosphoserine RI ipeptide. The 19-amino acid RII
peptide was synthesized by the M.I.T. Biopolymers Lab. The kinase reaction and purification
were performed according to the method of Etzkorn et. al. (1994). Briefly, in order to
phosphorylate 15 mgs of RII in a total reaction volume of 12 mls, cAMP-dependent protein
kinase (PKA, 1.3 nM units/mg; Sigma) was first activated by preincubation with cAMP.
Specifically, 2 mgs of PKA were preincubated at room temperature for 10 minutes in 537.5 p.l
H20, 10.75 p. of 1 mM 3'5'cAMP stock (Sigma), 26.9 pl of 50 mg/ml BSA stock, and 215 pl of 1 M
DTT stock. The following reagents were then added in order: 2.69 mls of 4 x buffer (1 x = 50 mM
Mops, 10 mM MgCl2, pH 7.1), 6.02 mls of H20, 215 p. of 0.1 M ATP stock (Sigma), and 15 mgs of
RII peptide which was dissolved in 1.075 mls of H20. The kinase reaction was incubated at
300C for 8 hours. The reaction was driven to completion by the further addition of PKA and
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ATP to the reaction mixture in the following manner: 0.4 mgs of PKA were preincubated for 10
minutes at room temperature in 270 pl of buffer containing 270 mM DTTI, .013 mM 3'5'cAMP, and
.085 mg/ml BSA. The enzyme was then added to the kinase reaction. After addition of a
further 72.9 pl of 0.1 mM ATP to the reaction mixture, the kinase reaction was incubated a
further 14 hours at 300C. Protein was removed from the kinase reaction by filtration in a
Centricon-30 (Amicon) prior to HPLC purification. 1-ml injections of the filtered kinase
reaction were loaded to a Vdack C18 reverse-phase column preequilibrated with 9:1 of 20 mM
NH40Ac:Acetonitrile (=buffer D). The column was developed in a gradient of 100% D--
>75%D/25%E over 15 minutes, where buffer E= a 1:9 mixture of 20mM NH40Ac: Acetonitrile.
Phosphorylated RII peaks were combined, lyophilized, and stored as a powder until
immediately prior to usage when they were diluted in H20, with the molarity of the resulting
solution calculated from the absorbance at 258 nm as compared to an HPLC-purified RII
standard.
Phosphatase Activity assays: (1): PNPP assay. para-Nitrophenyl phosphate
(Pharmacia) was dissolved to a 0.5 M stock solution in ddH20 and kept at -200C. Phosphatase
assays (1 mi assays) were carried out at ambient temperature in assay buffer containing 100 mM
Tris, pH 7.6, 50mM NaCI, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT, and 1 mg/ml BSA. Reactions
were started upon addition of the pNPP substrate to enzyme which had been preequilibrated
for four minutes in assay buffer containing stimulatory metals. When present, the final
concentration of MgC12 was 6 mM, CaC12 was 2 mM, and MnC12 was 2 mM. Enzyme
concentrations varied and are discussed in the legend to figures 4 and5. The reaction was
monitored by a spectrophotometer measuring the change in absorbance at 410 nm and an
extinction coefficient of 1.8 x 104 M-lcm-1. (2) RII phosphopeptide coupled assay. The coupled
assay was carried out in the same buffer as that used for pNPP assays. All coupled assays
contained 2 mM MnC12 in the assay buffer. Enzyme (again, enzyme concentrations are specified
in the legend to figures 4 and 5) was preequilibrated for four minutes in a cuvette containing
assay buffer, 2 mM MnC12, 6 gg of Q-sepharose purified PRPase, and 200 PM purified MESG.
The reaction was started by the addition of RII phosphopeptide to the cuvette, to a final
volume of 0.5 mls per reaction. The reaction was monitored by the change in OD360 over time as
the MESG base was liberated from the glycosidic bond to ribose. Employing a change in
extinction coefficient of 1.1 x 104 at 360 nm, the data were analyzed further on Kaleidagraph.
Results and Discussion
Three calcineurin (CNAal) deletion mutants were constructed: A311, A332, and A378. All
three were expressed as GST fusion proteins which were quite insoluble, resulting in the
formation of inclusion bodies over the range of temperatures, induction times, and IPTG levels
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Figure 1. GST fusion proteins were purified as described in the Materials and Methods section.
Their purity was assessed by SDS PAGE on a 12% polyacrylamide gel. Lanel, A378 mutant
protein, 4 pgg loaded; lane2, A311 mutant protein, 4 gg loaded; lane 3, A332 mutant protein, 4 gg
loaded; lane 4, A376 mutant protein reconstituted with CNB in the presence of Mn 2+, 5 jig
loaded.
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Figure 2. Western blot analysis was performed on a 12% SDS PAGE gel containing purified
calcineurin truncation mutants as described in the Materials and Methods section. Anti-
calcineurin B monoclonal primary antibody was used to detect the presence of CNB in the CNB-
reconstituted and purified A378/CNB enzyme. Lane 1, 0.3 jgg of non-reconstituted A378; lane2,
0.3 gLg of A378/CNB reconstituted enzyme (reconstituted in buffer containing Ca 2+); lane 3, 0.3 jig
of A378/CNB reconstituted enzyme (reconstituted in buffer containing Mn2+).
tested. Low yields of purified protein were obtained, with all three clones yielding less than
1 mg of protein per liter of bacterial culture (discussed in Materials and Methods section). By
SDS-PAGE, it seems that the A332 protein is much more stably expressed than the A311
protein, which seems to be degraded proteolytically in the cell (Figure 1). The A311 protein,
which contained all of regions of homology with X phage phosphatase (a small, 221-amino
acid, discussed in Chapter 1) and a truncation corresponding to the last residue of X PPase in
sequence alignments of X PPase and CN, possessed no detectable PNPPase activity, even at
high concentrations of both enzyme and substrate (800 nM enzyme, 80 mM pNPP-compared to
the Km of full length bovine brain calcineurin heterodimer of 10mM in the presence of
calmodulin-Martin et al., 1985). These results were found with two different A311 clones with
DNA from separate PCR reactions. Although the clones were only partially sequenced, the
assumption is that this truncation mutant is catalytically inactive with pNPP as the substrate
(RII activity was not assessed). The same was found to be true of A332, which contains all of
CNA catalytic domain up to and not including the beginning of the putative CNB binding
domain. Two separate clones were found to be similarly catalytically inactive at 800 nM
enzyme and 80 mM pNPP.
The only one out of the three proteins studied here to demonstrate catalytic activitytoward
both pNPP and RII phosphopeptide was the A378 truncation mutant. This protein lacks the
autoinhibitory domain and calmodulin binding domains, while retaining a functional CNB
binding domain (Clipstone et al., 1994). Reconstitution of A376 with human CNB was achieved
by incubation of GST-bound A376 with recombinant CNB extracts from BL21 (DE3) bacteria in
the presence of either Ca2+ or Mn 2+ for three hours (Wanatabe et al., 1994) washed, and eluted
with glutathione as described above (Figures 1 and 2). As can be seen from Figures 3 and 4 and
Table 1, the A378 pNPPase activity is completely Ca2+-independent, with the Mg 2+- and
Mg2+/Ca2+-stimulated Km and Vmax (i.e.,specific activity) activities yielding comparable
values for both parameters. As has been previously reported for the native enzyme (Ballou and
Fischer, 1986), Mn2+ stimulated the activity of the enzyme, resulting in an increase in the Vmax
by about 6-fold. Reconstitution of A378 with CNB in the presence of Mn 2+ yielded a Mn2+-
stimulated enzyme characterized by a 14-fold increase in Vmax and no change in Km. The Km
obtained for the A378 and A378/CNB enzymes, approximately 65 mM pNPP, is more than 6-
fold higher than the Km of 10 mM reported for bovine brain calcineurin in the presence of
calmodulin and Mn 2+ (Martin et al., 1985), implying a >6-fold decrease in the mutant's affinity
for pNPP.
Martin et al. find Vmax=3. 7 pCmol/min/mg for calcineurin, which is four-fold higher than
the reconstituted A378/CNB protein. This difference could potentially reside in the incomplete
reconstitution of A378/CNB, or the decrease in catalytic efficiency of the mutant enzyme due to
non-ideal folding. In any case, one strong implication of our studies regarding pNPPase activity
Kcat/KmMetal
(sec-1 )
205+/-25 LgM
688+/-146 pM
88+/-6 pM
117+/- 13 _pM
69+/-7 mM
70+/- 27 mM
58+/- 5 mM
74+/-15 mM
5.05
.12
2.05
1.25
.41
2.47x10 4
1.76x10 2
2.33x10 4
1.07x10 4
5.97
1.08
1.28 17.39
3800+/-424
107+/-21
1415+/-94
906+/-95
361+/-31
66+/-22
56+/-4
883+/-164
Table I. Kinetic parameters of deletion mutant enzymes in different conditions. Enzymes were incubated in the
presence of Mg 2+, Ca 2+, and/or Mn2+ as noted and enzyme assays were performed as discussed in the Materials and
Methods section. Reconstitution of the A378 mutant in Ca2+ or Mn 2+ is specified in the first column of the table.
Bovine brain calcineurin (Sigma) was reconstituted in the absence of added metal ions.
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Figure 3. Km determination and comparison. pNPP and coupled RII phosphopeptide assays
were performed on the A378 truncation mutant as well as the reconstituted A378/CNB enzyme.
Activity was measured in assay buffer containing 0.1 mM EDTA and 0.1 mM EGTA, as well as
containing Mn 2+, Mg 2+, and/or Ca2+, as follows. All RII experiments were performed in the
presence of Mn 2+. The RII activity of bovine brain calcineurin (Sigma) was measured at an
enzyme concentration of 33.75 nM and in the presence of 2 mM Mn 2+ (denoted "Sigma CN/Mn").
The RII activity of the A378 enzyme alone was tested at an enzyme concentration of 1 pM
(denoted "378/Mn"). The RII activity of the A378 enzyme which had been reconstituted in the
presence of Ca2+ (but assayed in the presence of Mn 2+) was measured at 240 nM reconstituted
enzyme (denoted "378/B/Ca/Mn"). The A378 enzyme reconstituted with CNB in the presence of
Mn 2+ and assayed for activity in the presence of Mn2+ was present at a concentration of 118 nM
(denoted "378/B/Mn"). Label identification of the reconstituted and non-reconstituted
enzymes, assayed for activity in buffer containing different metal ions, is the same for the
pNPP assay as for the coupled assay. Hence, the activity of "378/Mg/Ca" corresponds to that
of the unreconstituted A378 mutant, in the presence of Mg 2+ as well as Ca2+. Enzyme
concentrations for the pNPP assays were as follows: 378/Mg/Ca, 1 M ; 378/Mg2+, 1 pM;
378/Mn2+, 430nM; 378/B/Mn, 118nM.
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Figure 4. Specific Activity determination and comparison. See legend to Figure 3 for code used
to label the x-axis, describing a particular enzyme assayed under specific conditions.
is the importance of the CNB subunit to the catalytic efficiency of the enzyme. The apparent
increase in Vmax of the reconstituted protein implies that CNB is not merely regulating
substrate specificity, but catalytic efficiency as well. These results concur with previous reports
that CNB reconstitution with full length calcineurin, assayed in the presence of Mn 2+, yields a
large increase in Vmax relative to the full length enzyme incubated in the presence of
calmodulin and the absence of CNB (Perrino et al., 1992). The lack of change in activity of the
N. Crassa enzyme in response to CNB stimulation in a pNPPase assay described by Higuchi et
al. (1990) was later found to be dependent on the CNB isoform used to stimulate Norfl activity.
Consistent with our findings regarding CNB stimulation Ueki et al. (1993) found that CNBpl
reconstitution with full length Norfl and assayed for in the presence of calmodulin, Ca2+,
Mg 2+, and Mn 2+ doubled the specific activity of Norfl to levels slightly lower than those
obtained in our study (480-720 nmol/min/mg).
RII phosphopeptide phosphatase activity was monitored in a spectrophotometric assay
described previously (Etzkorn et al, 1994; Webb, 1992). Briefly, the inorganic phosphate
generated by calcineurin-catalyzed dephosphorylation of the RII peptide substrate serves as a
substrate for a second enzyme, purine ribosyl phosphorylase (PRP). PRP then catalyzes the
cleavage of the glycosidic bond between ribose and MESG (methyl thioguanosine), yielding
ribose-1-phosphate and the MESG base, the evolution of which can be monitored by a change in
OD360 (Figure 5). Purification of crude MESG and crude RII phosphopeptide by preparatory
HPLC were as described in Materials and Methods (Figures 6 and 7, respectively). Results of
the coupled assay are reported in Table I and Figures 3 and 4 ( an example of a representative
set of the kinetics reaction data used to characterize the kinetic parameters of the enzyme can
be found in Figure 8.)
The Mg 2+ and Mg 2+/Ca2+-stimulated activity of the A378 deletion mutant was too low to
detect using the coupled assay. Comparison of the Mn2+-stimulated activity of the A378 and
A378/CNB enzymes showed a 7-fold decrease in Km upon reconstitution of mutant with CNB as
well as a >8-fold increase in Vmax. These results point to a role for CNB in both regulation of
substrate affinity as well as catalytic efficiency of the enzyme. The CNB-reconstituted A378
mutant appears to bind RII phosphopeptide twice as tightly as reconstituted bovine brain CN
under similar conditions although its specific activity is 2-3 fold lower than that of the full
length CN, implying the tighter affinity of the mutant for RII phosphopeptide. These results
are complicated by the fact that Etzkorn et al., in their coupled assay, found bovine brain CN to
have a Km of 110 gM for RII phosphopeptide (almost 5-fold higher than the Km determined for
the same substrate and enzyme by the standard 32p-release assay; Chan et al., 1986) which is
similar to the Km found for the A378/CNB enzyme in this study. Possible differences may have
resulted from differences in the reconstitution buffer for bovine brain CN. Etzkorn et al. report a
6-hour incubation to achieve full activity, likely in the presence of Mn 2+, whereas in this
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(1) first step: dephosphorylation of RI phospho-
peptide substrate by calcineurin.
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(2) Second step: purine ribonucleoside phosphorylase scavenges
inorganic phosphate and catalyses the breakage of the glycosidic
bond, which causes a shift in Xmax characteristic of the free
base.
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Figure 5. Coupled Assay.
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Figure 6. Crude Methylthioguanosine, prepared according to the method of Webb (1992) was
purified by preparatory HPLC, with the active substrate for purine ribonucleotide
phosphorylase eluting slightly later than a large contaminating peak in an isocratic elution of
20 mM KOAc pH 5.5 which contained 10% methanol. The MESG displays a UV absorbance
profile as shown in the inset.
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Figure 7. RII peptide purification by preparatory HPLC according to the method of Etzkorn et
al. (1994). The phosphorylated peptide substrate is eluted at 17% B, while the
unphosphorylated peptide is eluted at 22%B (the peptides were resolved with a gradient from
100%A to 75%A/25%B where buffer A contained a 9:1 proportion of 20 mM NH40Ac:
Acetonitrile and buffer B contained a 1:9 proportion of 20 mM NH40Ac: Acetonitrile.
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Figure 8. Kinetic parameters were determined by analysis of Lineweaver-Burke
reciprocal plots of a set of individual kinetic assays. Shown here is a representative
plot of the reciprocal initial velocity of the A378 enzyme (not reconstituted with CNB)
in the presence of 2mM MnCl2 vs. the reciprocal RI, phosphopeptide substrate
concentrations, in units of M-1 . The standard deviation associated with each point did
not exceed 3%.
study, calcineurin purchased from Sigma was reconstituted in the absence of any added metal
cations for 6 hours. It is possible that the longer treatment of Mn 2+ results in a more activated
form of the enzyme with altered Kcat and Km values. This interpretation is consistent with the
notion of a slow conformational change of calcineurin to a more active form in the presence of
Mn 2+ (Ballou and Fischer, 1986). If so, extended Mn 2+ incubation times become critical in order
to compare results obtained from different studies (a suggestion also made by Chan et al., 1986).
In our study, A378 reconstituted with CNB in Ca 2+ has a slightly higher Km than the same
enzyme reconstituted in Mn2+ (117 iM vs. 88 pM), as well as exhibiting only 65% of the specific
activity found with the Mn 2+-reconstituted enzyme (which was incubated in Mn 2+ for extended
periods of time beyond the 4 -minute preincubation in Mn 2+ included in the assay).
The positive effect of CNB on both the Km and Kcat with RII phosphopeptide as substrate
demonstrated in this study corroberate results obtained by Perrino et al. (1995) on a A420 enzyme
containing both the CNB-binding- and CAM-binding-domains in a 32-P-release RII
phosphopeptide assay. They find that their deletion mutant exhibits Ca2+-independent
activity in Mg 2+ basal stimulation assays, with only a slightly higher Vmax attained in the
presence of Ca 2+/CAM combined than in the presence of one or the other (perhaps alluding to
the possibility of additional inhibitory residues in the CAM binding domain, alluded to in the
proteolysis experiments of Hubbard and Klee (1989). Direct comparison of their results with
ours in order to further clarify this issue and assess the effects of the further C-terminal
truncation on both specific activity and Km values are difficult because the coupled assay is
unable to detect Ca2+/Mg 2+-stimulated activity.
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